Monzr Al Malki, MD, Hematology, Duarte, CA, City of Hope's Helford Clinical Research Hospital

MonzrMAl MalkiMD

Hematology Duarte, CA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Assistant Professor Hematology and Hematopoietic Cell Transplantation

Dr. Al Malki is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Al Malki's full profile

Already have an account?

Summary

  • Dr. Monzr Al Malki is a hematologist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from Damascus University Faculty of Medicine and has been in practice 14 years. He also speaks multiple languages, including Arabic and Spanish. He specializes in hematologic oncology and myeloproliferative disorder hematology-oncology and is experienced in aplastic anemia, hematopoietic stem cell transplantation, acute myeloid leukemia, hodgkin's lymphoma, and multiple myeloma.

Education & Training

  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineMedicalSchool

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2021
  • MA State Medical License
    MA State Medical License 2008 - 2016
  • RI State Medical License
    RI State Medical License 2008 - 2016
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
    Monzr M. Al Malki, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Updated Analysis: Novel Machine-Learning-Based Sepsis Prediction Model for Patients Undergoing Hematopoietic Stem Cell Transplantation (Early Sepsis Prediction/Identif...
    Monzr M. Al Malki, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...
    Monzr M. Al Malki, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Downregulation of Mir-142 Promotes Leukemia Growth in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): A Possible Novel Therapeutic Target? 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Half-Matches Open Door to Bone Marrow Transplant for More Patients
    Half-Matches Open Door to Bone Marrow Transplant for More PatientsMay 06, 2019

Professional Memberships

Other Languages

  • Arabic, Spanish

Hospital Affiliations